Authors
Latest:
Prescribing Trend of Pioglitazone After Safety Warning Release in KoreaThe pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone users.
Latest:
Health Insurance Design and Conservative Therapy for Low Back PainThis study examined the association between health insurance design features and choice of physical therapy or chiropractic care by patients with new-onset low back pain.
Latest:
Adherence and Dosing Frequency of Common Medications for Cardiovascular PatientsIn this database analysis, greater adherence was observed for once-daily dosing compared with twice-daily dosing with chronic-use prescription medications used by patients with cardiovascular disease.
Latest:
Emergency Department Nonurgent Visits in Iran: Prevalence and Associated FactorsInappropriate use of emergency department resources in Iran is a frequent problem that calls for effective approaches and interventions.
Latest:
Patients’ Access to 2018 FDA-Approved Drugs 1 Year Post Approval2018 was a landmark year for new drug approvals. However, patients’ access to these novel drugs varied by drug category and enrolled health plan.
Latest:
Economic Model for Emergency Use Authorization of Intravenous PeramivirThe US Food and Drug Administration granted emergency use authorization of intravenous neuraminidase inhibitors for patients with 2009 influenza A (H1N1), creating a need for economic studies.
Latest:
More Comprehensive Discussion of CRC Screening Associated With Higher ScreeningMore comprehensive discussion of colorectal screening by primary care physicians was associated with higher screening rates among adults aged 51 to 80 years who were overdue for screening.
Latest:
Cost Per Response Analysis of Strategies for Chronic Immune ThrombocytopeniaThis decision tree model estimates the cost per response and incremental cost per additional responder for romiplostim, eltrombopag, and “watch and rescue” for immune thrombocytopenia.
Latest:
Multipayer Primary Care Transformation: Impact for Medicaid Managed Care BeneficiariesThe Michigan Primary Care Transformation project generated cost savings among adults in Medicaid managed care, particularly high-risk adults, while largely maintaining quality of care.
Latest:
Evaluating the Efficacy of a Bundled Chronic Condition Management ProgramA chronic disease management company presents promising preliminary results from their remote intensive behavioral counseling intervention, aimed at addressing type 2 diabetes.
Latest:
Telehealth: An Important Tool in Achieving the Goals of the ACO Program and Why Restrictions Should Be Lifted in Final ACO RuleLifting section 1834(m) restrictions on telehealth services would help ACOs to utilize this beneficial tool to achieve their cost, quality, access, and patient engagement goals.
Latest:
Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung CancerThis review assesses the current molecular testing landscape for non–small-cell lung cancer in the United States.
Latest:
Patient Out-of-Pocket Payments for Oral Oncolytics: Results From a 2009 US Claims Data AnalysisOut-of-pocket payments differ widely among oral oncolytic options. As cost for therapy becomes a greater part of treatment decisions, an understanding of patient out-of-pocket cost will be critical in informing choices.
Latest:
The Influence of Provider Characteristics and Market Forces on Response to Financial IncentivesWe determine a specialist physician phenotype responsive to financial incentives that may be leveraged to identify physicians and markets well-suited for participation in alternative payment models.
Latest:
The Promise and Peril of Healthcare ForecastingHealthcare forecasting could facilitate personalized insurance benefit design and clinical decision support systems, although increased socioeconomic disparities could result from selective disease management programs.
Latest:
Bridges to Excellence—Recognizing High-Quality Care: Analysis of Physician Quality and Resource UsePhysicians recognized as high quality by Bridges to Excellence performed better than their peers on claimsbased quality measures and, in some cases, on resource use measures.
Latest:
The Impact of Patient Assistance Programs and the 340B Drug Pricing Program on Medication CostExamining the financial impact that patient assistance programs and the 340B Drug Pricing Program have on improving medication cost.
Latest:
Medication Adherence: The Search for Interventions That WorkCurrent interventions to improve medication adherence lack a clear, uniform approach by which patient compliance can be universally improved.
